0001171843-16-010659.txt : 20160614 0001171843-16-010659.hdr.sgml : 20160614 20160614170113 ACCESSION NUMBER: 0001171843-16-010659 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160610 FILED AS OF DATE: 20160614 DATE AS OF CHANGE: 20160614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDENBERG DAVID M CENTRAL INDEX KEY: 0001029578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 161713643 MAIL ADDRESS: STREET 1: UBS GLOBAL ASSET MANAGEMENT (US) INC. STREET 2: 51 WEST 52ND STREET CITY: NEW YORK STATE: NY ZIP: 10019 4 1 f4_dgoldenberg061416.xml OWNERSHIP DOCUMENT X0306 4 2016-06-10 0 0000722830 IMMUNOMEDICS INC IMMU 0001029578 GOLDENBERG DAVID M C/O IMMUNOMEDICS, INC 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 1 0 0 CSO & Chairman of the BOD Common Stock 2016-06-10 4 M 0 81990 2.50 A 2573731 D Common Stock 2016-06-10 4 M 0 10050 2.63 A 2583781 D Common Stock 2016-06-10 4 S 0 92040 3.0547 D 2491741 D Common Stock 2016-06-10 4 M 0 11326 2.63 A 3320707 I See Footnote Common Stock 2016-06-10 4 S 0 11326 3.0709 D 3309381 I See Footnote Common Stock 2016-06-13 4 M 0 139950 2.63 A 2631691 D Common Stock 2016-06-13 4 S 0 139950 3.0198 D 2491741 D Common Stock 2016-06-13 4 M 0 128674 2.63 A 3438055 I See Footnote Common Stock 2016-06-13 4 S 0 128674 3.0247 D 3309381 I See Footnote Stock Option (right to buy) 2.50 2016-06-10 4 M 0 81990 0 D 2016-06-10 Common Stock, par value $0.01 per share 81990 0 D Stock Option (right to buy) 2.63 2016-06-10 4 M 0 10050 0 D 2016-06-14 Common Stock, par value $0.01 per share 10050 139950 D Stock Option (right to buy) 2.63 2016-06-10 4 M 0 11326 0 D 2016-06-14 Common Stock, par value $0.01 per share 11326 128674 I See Footnote Stock Option (right to buy) 2.63 2016-06-13 4 M 0 139950 0 D 2016-06-14 Common Stock, par value $0.01 per share 139950 0 D Stock Option (right to buy) 2.63 2016-06-13 4 M 0 128674 0 D 2016-06-14 Common Stock, par value $0.01 per share 128674 0 I See Footnote Includes a total of 190,000 shares held as joint tenants by the reporting person and his spouse, Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, the Issuer's President and Chief Executive Officer. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.04 to $3.085. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein. The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.07 to $3.08. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $2.96 to $3.12. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.00 to $3.12. These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter. These stock options were granted pursuant to the Issuer's 2002 Stock Option Plan, and vested over four years at a rate of 25% per year. The reporting person's spouse was granted these stock options pursuant to the Issuer's 2002 Stock Incentive Plan. /s/ David M. Goldenberg 2016-06-14